Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $973.72M.
ENTERPRISE VALUE (EV)
$973.72M
Cullinan Therapeutics, Inc.
Market Cap
$1.06B
Enterprise Value (EV)
$973.72M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cullinan Therapeutics, Inc. (CGEM) | $1.06B | $973.72M |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | $1.31B |
| Janux Therapeutics, Inc. (JANX)vs › | $1.04B | $1.04B |
| IRadimed Corporation (IRMD)vs › | $1.09B | $1.03B |
| Immatics N.V. (IMTX)vs › | $1.04B | $792.28M |
| Castle Biosciences, Inc. (CSTL)vs › | $1.04B | $1.01B |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.03B | $2.86B |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | $999.04M |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | $1.92B |
| Replimune Group, Inc. (REPL)vs › | $1.11B | $1.04B |
Market Cap
$1.06B
Total Debt
$1.90M
Cash
$88.33M
Enterprise Value
$973.72M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
